Ying J - Search Results

1

Adjuvant albumin-bound paclitaxel combined with S-1 vs. oxaliplatin combined with capecitabine after D2 gastrectomy in patients with stage III gastric adenocarcinoma: a phase III multicenter, open-label, randomized controlled clinical trial protocol.

Cheng X, Wu D, Xu N, Chen L, Yan Z, Chen P, Zhou L, Yu J, Cui J, Li W, Wang C, Feng W, Wei Y, Yu P, Du Y, Ying J, Xu Z, Yang L, Zhang Y. Cheng X, et al. Among authors: ying j. BMC Cancer. 2021 Jan 12;21(1):56. doi: 10.1186/s12885-020-07772-7. BMC Cancer. 2021. PMID: 33435909 Free PMC article.

2

Docetaxel plus oxaliplatin (DOCOX) as a second-line treatment after failure of fluoropyrimidine and platinum in Chinese patients with advanced gastric cancer.

Zhong H, Zhang Y, Ma S, Ying JE, Yang Y, Yong D, Hang X, Sun Q, Zhong B, Wang D. Zhong H, et al. Anticancer Drugs. 2008 Nov;19(10):1013-8. doi: 10.1097/CAD.0b013e328314b5ab. Anticancer Drugs. 2008. PMID: 18827567

3

[Significance of multidrug resistance gene-associated proteins in the postoperative adjuvant chemotherapy for gastric carcinoma and the prognosis].

Yu PF, Guo JM, Xu Q, Ying JE, Wang XJ, Cheng XD, Wang XB, Yu CD. Yu PF, et al. Zhonghua Wei Chang Wai Ke Za Zhi. 2010 Apr;13(4):289-93. Zhonghua Wei Chang Wai Ke Za Zhi. 2010. PMID: 20422488 Chinese.

4

S-1 combined with oxaliplatin as first line chemotherapy for Chinese advanced gastric cancer patients.

Liu B, Ying J, Luo C, Xu Q, Zhu L, Zhong H. Liu B, et al. Among authors: ying j. Hepatogastroenterology. 2012 Mar-Apr;59(114):649-53. doi: 10.5754/hge11893. Hepatogastroenterology. 2012. PMID: 22328264 Clinical Trial.

5

Prognostic and predictive value of metastatic lymph node ratio in stage III gastric cancer after D2 nodal dissection.

Chen Y, Li C, Du Y, Xu Q, Ying J, Luo C. Chen Y, et al. Among authors: ying j. Oncotarget. 2017 Aug 7;8(41):70841-70846. doi: 10.18632/oncotarget.19998. eCollection 2017 Sep 19. Oncotarget. 2017. PMID: 29050324 Free PMC article.

6

Treatment strategy and prognostic factors for Krukenberg tumors of gastric origin: report of a 10-year single-center experience from China.

Yu P, Huang L, Cheng G, Yang L, Dai G, Ying J, Du Y. Yu P, et al. Among authors: ying j. Oncotarget. 2017 Aug 1;8(47):82558-82570. doi: 10.18632/oncotarget.19759. eCollection 2017 Oct 10. Oncotarget. 2017. PMID: 29137284 Free PMC article.

7

Efficacy and safety of weekly nab-paclitaxel plus gemcitabine in Chinese patients with metastatic adenocarcinoma of the pancreas: a phase II study.

Xu R, Yu X, Hao J, Wang L, Pan H, Han G, Xu J, Zhang Y, Yang S, Chen J, Ying J, Dai G, Li M, Begic D, Lu B, Shen L. Xu R, et al. Among authors: ying j. BMC Cancer. 2017 Dec 22;17(1):885. doi: 10.1186/s12885-017-3887-z. BMC Cancer. 2017. PMID: 29273007 Free PMC article. Clinical Trial.

8

Surufatinib in advanced extrapancreatic neuroendocrine tumours (SANET-ep): a randomised, double-blind, placebo-controlled, phase 3 study.

Xu J, Shen L, Zhou Z, Li J, Bai C, Chi Y, Li Z, Xu N, Li E, Liu T, Bai Y, Yuan Y, Li X, Wang X, Chen J, Ying J, Yu X, Qin S, Yuan X, Zhang T, Deng Y, Xiu D, Cheng Y, Tao M, Jia R, Wang W, Li J, Fan S, Peng M, Su W. Xu J, et al. Among authors: ying j. Lancet Oncol. 2020 Nov;21(11):1500-1512. doi: 10.1016/S1470-2045(20)30496-4. Epub 2020 Sep 20. Lancet Oncol. 2020. PMID: 32966811 Clinical Trial.

9

Camrelizumab Combined with Chemotherapy Followed by Camrelizumab plus Apatinib as First-line Therapy for Advanced Gastric or Gastroesophageal Junction Adenocarcinoma.

Peng Z, Wei J, Wang F, Ying J, Deng Y, Gu K, Cheng Y, Yuan X, Xiao J, Tai Y, Wang L, Zou J, Zhang Y, Shen L. Peng Z, et al. Among authors: ying j. Clin Cancer Res. 2021 Jun 1;27(11):3069-3078. doi: 10.1158/1078-0432.CCR-20-4691. Epub 2021 Mar 25. Clin Cancer Res. 2021. PMID: 33766817 Clinical Trial.

10

Intratumoral OH2, an oncolytic herpes simplex virus 2, in patients with advanced solid tumors: a multicenter, phase I/II clinical trial.

Zhang B, Huang J, Tang J, Hu S, Luo S, Luo Z, Zhou F, Tan S, Ying J, Chang Q, Zhang R, Geng C, Wu D, Gu X, Liu B. Zhang B, et al. Among authors: ying j. J Immunother Cancer. 2021 Apr;9(4):e002224. doi: 10.1136/jitc-2020-002224. J Immunother Cancer. 2021. PMID: 33837053 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,140 results

Search Page

Filters